What is Oritavancin and how does it work?
Oritavancin is a novel lipoglycopeptide antibiotic that is used for the treatment of acute bacterial skin and skin structure infections. It works by inhibiting the bacterial cell wall synthesis, leading to cell death of the bacteria causing the infection.

How is Oritavancin administered?
Oritavancin is typically administered as a single dose injection, making it convenient for patients with skin infections that require treatment with an antibiotic. The single dose regimen helps to ensure compliance and reduces the risk of missed doses.

What are the advantages of using Oritavancin for skin infections?
Oritavancin offers several advantages for the treatment of skin infections. Its long half-life allows for a single dose treatment regimen, reducing the frequency of administrations needed compared to other antibiotics. This can help improve patient compliance and simplify treatment regimens.

Is Oritavancin effective against a wide range of bacterial infections?
Oritavancin is effective against a variety of gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). This broad spectrum of activity makes it a valuable option for the treatment of skin infections caused by these resistant organisms.

What are the potential side effects of Oritavancin?
Common side effects of Oritavancin include nausea, headache, and diarrhea. Some patients may also experience injection site reactions, such as pain or redness at the site of administration. It is important to discuss any potential side effects with your healthcare provider before starting treatment with Oritavancin.